EC Number |
Inhibitors |
Structure |
---|
2.3.1.87 | 2-bromo-N-[2-(5-fluoro-1-benzothien-3-yl)ethyl]acetamide |
IC50: 0.00039 mM |
|
2.3.1.87 | 9-carboxy-11-nor-delta-9-tetrahydrocannabinol |
significantly reduces norepinephrine-induced arylalkylamine N-acetyltransferase activity |
|
2.3.1.87 | acetyl-CoA-tryptamine |
IC50: 0.00041 mM, GST-AANAT fusion protein |
|
2.3.1.87 | acetyl-CoA-tryptamine |
IC50: 0.00062 mM, GST-AANAT fusion protein |
|
2.3.1.87 | acetyl-CoA-tryptamine |
IC50: 0.0008 mM, GST-AANAT fusion protein |
|
2.3.1.87 | alpha-trifluoromethyltryptamine |
modest, competitive |
|
2.3.1.87 | bromoacetyltryptamine |
IC50: 0.0014 mM |
|
2.3.1.87 | bromoacetyltryptamine |
IC50: 0.00143 mM, GST-AANAT fusion protein |
|
2.3.1.87 | bromoacetyltryptamine |
IC50: 0.00128 mM, GST-AANAT fusion protein |
|
2.3.1.87 | bromoacetyltryptamine |
IC50: 0.0051 mM, GST-AANAT fusion protein |
|